These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9303971)
1. [Access to bone marrow transplantation in acute myeloblastic leukemia. Study of 52 patients treated in a single center]. Tomás JF; Calvo JM; Gómez-García de Soria V; Pinilla I; Figuera A; Fernández-Rañada JM Med Clin (Barc); 1997 May; 109(1):12-5. PubMed ID: 9303971 [TBL] [Abstract][Full Text] [Related]
2. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients]. Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484 [TBL] [Abstract][Full Text] [Related]
3. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome. Tomás F; Gómez-García de Soria V; López-Lorenzo JL; Arranz R; Figuera A; Cámara R; Alegre A; Fernández-Rañada JM Bone Marrow Transplant; 1996 Jun; 17(6):979-84. PubMed ID: 8807103 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [TBL] [Abstract][Full Text] [Related]
5. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia. Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. Keating S; Suciu S; de Witte T; Mandelli F; Willemze R; Resegotti L; Broccia G; Thaler J; Labar B; Damasio E; Bizzi B; Rotoli B; Vekhoff A; Muus P; Petti MC; Dardenne M; Solbu G; Vegna ML; Zittoun RA Bone Marrow Transplant; 1996 Jun; 17(6):993-1001. PubMed ID: 8807105 [TBL] [Abstract][Full Text] [Related]
7. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G; J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission. Ferrant A; Doyen C; Delannoy A; Cornu G; Martiat P; Latinne D; De Bruyère M; Bosly A; Michaux JL; Sokal G Bone Marrow Transplant; 1991 Apr; 7(4):303-9. PubMed ID: 2070137 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centre. Gamberi B; Bandini G; Visani G; Rosti G; Cenacchi A; Motta MR; Fruet F; Calori E; Rizzi S; Tosi P Bone Marrow Transplant; 1994 Jul; 14(1):69-72. PubMed ID: 7951122 [TBL] [Abstract][Full Text] [Related]
14. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience. Yavuz S; Paydas S; Disel U; Sahin B Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Chim CS; Lie AK; Liang R; Au WY; Kwong YL Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712 [TBL] [Abstract][Full Text] [Related]
18. [Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia]. Chen H; Ren HY; Guo NL; Huang XJ; Liu KY; Xu LP; Zhang YC; Zheng H; Wu T; Liu DH; Yang SM; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):87-90. PubMed ID: 14990046 [TBL] [Abstract][Full Text] [Related]
19. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study. Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987 [TBL] [Abstract][Full Text] [Related]
20. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia. Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]